首页 | 医院概况 | 组织结构 | 新闻中心 | 科研成果 | 诊疗中心 | 专家团队 | 重点实验室 | 《医学参考报》 | 联系我们 | 友情链接
新闻中心
科研成果
诊疗中心
医院概况
    哈尔滨医科大学血液肿瘤医院前身为哈尔滨医科大学附属第一医院血液内科,由1959年建立的普通内科血液专业组发展而来。50多年来,经过几代人的不懈努力,发生了翻天覆地的变化...[详细]
医院院长
周晋 教授 主任医师
哈尔滨医科大学血液肿瘤医院院长
中文介绍 English
 
您当前的位置:黑龙江省血液肿瘤研究所 > 其它 > 正文
Brief Introduction
2011-09-13  【 字体:
    Dr. Jin Zhou is the director of Heilongjiang Province Hematology and Oncology Institute, and dean of the First Affiliated Hospital of Harbin Medical University.He is also the head of Hematology Department and a full professor in his hospital. Dr. Zhou received his Bachelor of Medical Science degree from the Fourth Military Medical University in 1983, Master of Medical Science degree on Internal Medicine in Harbin Medical University in 1992, and Ph.D degree on Hematology and Oncology in Suzhou University in 1995. He then completed his post-doctoral training in Calgary University in Canada and later worked briefly as a visiting scholar at Massachusetts General Hospital in the U.S., Japan, Korea, Britain, and Russia.
    Dr. Jin Zhou is a committee member of China Association of Hematology, standing committee member of China Hematologists and Oncologists Association, member of American Association of Hematology, chairman of Hematology Association in Heilongjiang Province, member of China National Medical Graduates Evaluation Committee, editor of China Journal of Hematology, editor of China Clinical Hematology,and editor in chief ofMedical Reference Paper – Hematology. Dr. Zhou is an honored receiver of the State Council Special Government Allowances.influences potassium and calcium channels in cardiac cell membrane to change intracellular calcium level. This clarified ATO’s molecular pharmacological mechanism on cardiac cells which may eventually cause long Q-T syndrome.
    Dr. Zhou has been teaching and practicing actively on hematology clinical and basic research for more than 20 years. Dr. Zhou is interested in arsenic trioxide(ATO) infusion treatment for acute promyelocytic leukemia (APL), its effect on leukemia cell differentiation or apoptosis, and its adverse effects such as leukocytosis and long Q-T syndrome.He then established a new way--- “ATO slow continuous infusion method” that increased ATO therapeutic efficacy while decreased its toxicity, especially the leukocytosis and fatal cerebrovascular accident. Currently this “ATO slow continuous infusion method” has been adapted and used by healthcare providers widely and proved to be a effective regimen for APL. In the clinical trials, Dr. Zhou found ATO
    By using a transcranial Doppler ultrasound, Dr. Zhou set up a non-invasive and dynamic monitor system for the brain pressure changes in central nervous system leukemia patients. Based on this innovated technique, Dr. Zhou established “temporarily opening the blood brain barrier by distal intravenous mannitol injection” method to improve the permeability of arsenic trioxide into the brain tissue. These pioneer work opened up the precedent of minimally invasive inspection, prevention and treatment regimen for leukemia patients, especially for those suffer central nervous system leukemia.
    Dr. Zhou published over 30 papers in peer reviewed journals, among which “Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia” was recently published in the “Blood” (IF 10.555). Dr. Zhou received over ten national and provincial Science and Technology Awards, nine National patents, and one national invention patent.His research projects are funded by The National Natural Science Foundation of China, The National 863 Projects, the Heilongjian Natural Science Foundation, and the Heilongjiang Outstanding Youth Foundation.
    Professor Zhou was awarded the first “China Physician Award” of China Medical Association in 2003, and multiple times of“outstanding physician” of National Healthcare Providers, “National Medical Ethics Model” and “National Medalist on Labor day”.
 

 

来源:  编辑:管理员


哈尔滨医科大学 哈医大一院
Pubmed检索 《Blood》 《NatureScience Nature AsiaScience Daily
中华人民共和国科学技术部 中华人民共和国教育部 中华人民共和国卫生部 国家自然科学基金委员会 黑龙江科学技术厅
中华医学会 中国医学网 血液健康网 干细胞科学网 科学网
哈尔滨医科大学血液肿瘤医院版权所有 保留所有权利 黑ICP备09002418号 Copyright 20015-2025 hljblood.org.cn All Rights Reserved